Top Pharmaceuticals companies in the world by EBT Margin

This ranking features the top 2,357 Pharmaceuticals companies in the world ranked by EBT Margin, averaging a EBT Margin of -854,801.29%, for January 15, 2025.

Global

Pharmaceuticals

#	Name	EBT Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	94,778.84%	Sept. 30, 2024	USD 12.74	-6.60%	United States
2	Linc AB 2 LINC.ST	18,249.32%	Dec. 31, 2023	USD 8.02	0.46%	Sweden
3	Roivant Sciences Ltd. 3 ROIV	3,408.33%	March 31, 2024	USD 10.94	1.86%	United Kingdom
4	Agios Pharmaceuticals, Inc. 4 AGIO	2,212.98%	Sept. 30, 2024	USD 33.32	-2.86%	United States
5	Eledon Pharmaceuticals, Inc. 5 ELDN	2,168.39%	Sept. 30, 2024	USD 3.71	-4.63%	United States
6	Oramed Pharmaceuticals Inc. 6 ORMP	1,518.25%	March 31, 2024	USD 2.36	NA	United States
7	MPH Health Care AG 7 93M1.DE	411.35%	Dec. 31, 2023	USD 24.32	-0.24%	Germany
8	RedHill Biopharma Ltd. 8 RDHL	367.75%	Dec. 31, 2023	USD 5.51	-1.08%	Israel
9	Pharmena S.A. 9 PHR.WA	354.34%	Dec. 31, 2023	USD 1.01	1.23%	Poland
10	Alembic Limited 10 ALEMBICLTD.NS	176.80%	March 31, 2024	USD 1.41	4.27%	India
11	Maravai LifeSciences Holdings, Inc. 11 MRVI	159.33%	Sept. 30, 2024	USD 4.54	-7.91%	United States
12	TaiGen Biopharmaceuticals Holdings Limited 12 4157.TWO	116.53%	Dec. 31, 2023	USD 0.32	0.12%	Taiwan
13	Formycon AG 13 FYB.DE	101.77%	Dec. 31, 2023	USD 60.50	-1.24%	Germany
14	L&C Bio Co., Ltd 14 290650.KQ	91.39%	Dec. 31, 2023	USD 16.30	-3.69%	South Korea
15	Alar Pharmaceuticals Inc. 15 6785.TWO	83.34%	Dec. 31, 2023	USD 4.09	5.18%
16	Bioventix PLC 16 BVXP.L	77.71%	June 30, 2024	USD 39.06	2.49%	United Kingdom
17	Uniphos Enterprises Limited 17 UNIENTER.NS	76.89%	March 31, 2024	USD 1.74	3.76%	India
18	Royalty Pharma plc 18 RPRX	75.66%	Sept. 30, 2024	USD 30.03	0.13%	United States
19	Imeik Technology Development Co.,Ltd. 19 300896.SZ	75.12%	Dec. 31, 2023	USD 23.99	3.90%	China
20	Cathay Chemical Works Inc. 20 1713.TW	73.09%	Dec. 31, 2023	USD 1.38	0.78%	Taiwan
21	Pro Medicus Limited 21 PME.AX	72.13%	June 30, 2024	USD 157.25	0.24%	Australia
22	Ajinomoto (Malaysia) Bhd 22 2658.KL	71.11%	March 31, 2024	USD 3.29	-0.45%	Malaysia
23	Kangji Medical Holdings Limited 23 9997.HK	63.58%	Dec. 31, 2023	USD 0.77	2.02%	China
24	SIGA Technologies, Inc. 24 SIGA	63.52%	Sept. 30, 2024	USD 6.33	4.46%	United States
25	Cipher Pharmaceuticals Inc. 25 CPH.TO	59.92%	Dec. 31, 2023	USD 9.40	-4.39%	Canada
26	Clinuvel Pharmaceuticals Limited 26 CUV.AX	57.47%	June 30, 2024	USD 7.32	6.16%	Australia
27	Protagonist Therapeutics, Inc. 27 PTGX	53.45%	Sept. 30, 2024	USD 36.67	-1.26%	United States
28	Shandong Shanda Wit Science and Technology Co., Ltd. 28 000915.SZ	53.35%	Dec. 31, 2023	USD 3.77	2.84%	China
29	Santhera Pharmaceuticals Holding AG 29 SANN.SW	53.01%	Dec. 31, 2023	USD 14.50	8.00%	Switzerland
30	Yantai Zhenghai Biotechnology Co., Ltd. 30 300653.SZ	52.80%	Dec. 31, 2023	USD 2.82	2.48%	China
31	United Therapeutics Corporation 31 UTHR	52.17%	Sept. 30, 2024	USD 364.70	0.50%	United States
32	Shanghai Yizhong Pharmaceutical Co., Ltd. 32 688091.SS	51.88%	Dec. 31, 2023	USD 4.94	3.02%	China
33	Halozyme Therapeutics, Inc. 33 HALO	50.68%	Sept. 30, 2024	USD 53.83	-0.57%	United States
34	G&E Herbal Biotechnology Co., Ltd. 34 4911.TWO	49.88%	Dec. 31, 2023	USD 1.63	0.49%
35	Pak Fah Yeow International Limited 35 0239.HK	49.67%	Dec. 31, 2023	USD 0.31	0.39%	Hong Kong
36	Giant Biogene Holding Co., Ltd. 36 2367.HK	49.52%	Dec. 31, 2023	USD 6.64	6.03%	China
37	Beijing Succeeder Technology Inc. 37 688338.SS	48.95%	Dec. 31, 2023	USD 3.27	2.18%	China
38	Andon Health Co., Ltd. 38 002432.SZ	48.91%	Dec. 31, 2023	USD 5.45	2.10%	China
39	Shanghai MicroPort Endovascular MedTech Co., Ltd. 39 688016.SS	48.70%	Dec. 31, 2023	USD 15.35	4.46%	China
40	GNI Group Ltd. 40 2160.T	48.49%	Dec. 31, 2023	USD 19.77	1.11%	Japan
41	Shenzhen New Industries Biomedical Engineering Co., Ltd. 41 300832.SZ	48.17%	Dec. 31, 2023	USD 8.51	2.10%	China
42	Mizuho Medy Co.,Ltd. 42 4595.T	48.16%	Dec. 31, 2023	USD 9.59	-1.93%	Japan
43	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. 43 ECILC.IS	47.88%	Dec. 31, 2023	USD 1.24	-0.32%	Turkey
44	Beijing SL Pharmaceutical Co., Ltd. 44 002038.SZ	45.65%	Dec. 31, 2023	USD 1.04	1.87%	China
45	Shionogi & Co., Ltd. 45 4507.T	45.57%	March 31, 2024	USD 14.22	-0.40%	Japan
46	Ind-Swift Laboratories Limited 46 INDSWFTLAB.NS	45.42%	March 31, 2024	USD 1.16	-0.19%	India
47	Beijing Tong Ren Tang Chinese Medicine Company Limited 47 3613.HK	45.10%	Dec. 31, 2023	USD 1.04	1.48%	Hong Kong
48	Novo Nordisk A/S 48 NOVO-B.CO	45.07%	Dec. 31, 2023	USD 81.56	-2.90%	Denmark
49	BioArctic AB (publ) 49 BIOA-B.ST	44.88%	Dec. 31, 2023	USD 17.87	3.09%	Sweden
50	Tonghua Dongbao Pharmaceutical Co., Ltd. 50 600867.SS	44.41%	Dec. 31, 2023	USD 1.05	3.24%	China

1 2 3 4 … 48

Frequently Asked Questions

Which Pharmaceuticals company has the highest EBT Margin ?

The Pharmaceuticals company with the highest EBT Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 94,778.84%.
Which Pharmaceuticals company has the lowest EBT Margin ?

The Pharmaceuticals company with the lowest EBT Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,956,524,900.00%.

What are the top 10 Pharmaceuticals companies by EBT Margin ?

The top 10 Pharmaceuticals companies the Global by EBT Margin are Inhibrx Biosciences, Inc., Linc AB, Roivant Sciences Ltd., Agios Pharmaceuticals, Inc., Eledon Pharmaceuticals, Inc., Oramed Pharmaceuticals Inc., MPH Health Care AG, RedHill Biopharma Ltd., Pharmena S.A. and Alembic Limited.
What are the bottom 10 Pharmaceuticals companies by EBT Margin ?

The bottom 10 Pharmaceuticals companies by EBT Margin are Inhibikase Therapeutics, Inc., Molecure S.A., ZyVersa Therapeutics, Inc., Inovio Pharmaceuticals, Inc., BrightPath Biotherapeutics Co., Ltd., Genomtec S.A., Allogene Therapeutics, Inc., Forte Biosciences, Inc., OncoZenge AB (publ) and Immix Biopharma, Inc..